These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 35561965)

  • 1. Drug repurposing to overcome microbial resistance.
    Jampilek J
    Drug Discov Today; 2022 Jul; 27(7):2028-2041. PubMed ID: 35561965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review.
    Foletto VS; da Rosa TF; Serafin MB; Bottega A; Hörner R
    Int J Antimicrob Agents; 2021 Sep; 58(3):106380. PubMed ID: 34166776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
    Konreddy AK; Rani GU; Lee K; Choi Y
    Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria.
    Liu Y; Tong Z; Shi J; Li R; Upton M; Wang Z
    Theranostics; 2021; 11(10):4910-4928. PubMed ID: 33754035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repurposing for antimicrobial discovery.
    Farha MA; Brown ED
    Nat Microbiol; 2019 Apr; 4(4):565-577. PubMed ID: 30833727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant
    Cheng YS; Sun W; Xu M; Shen M; Khraiwesh M; Sciotti RJ; Zheng W
    Front Cell Infect Microbiol; 2018; 8():438. PubMed ID: 30662875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing of gallium-based drugs for antibacterial therapy.
    Bonchi C; Imperi F; Minandri F; Visca P; Frangipani E
    Biofactors; 2014; 40(3):303-12. PubMed ID: 24532037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics.
    Liu Y; Lu Y; Xu Z; Ma X; Chen X; Liu W
    Drug Discov Today; 2022 Jul; 27(7):1961-1973. PubMed ID: 35192926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing.
    Boyd NK; Teng C; Frei CR
    Front Cell Infect Microbiol; 2021; 11():684515. PubMed ID: 34079770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria.
    Peyclit L; Baron SA; Rolain JM
    Front Cell Infect Microbiol; 2019; 9():193. PubMed ID: 31245302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming of antibiotics to combat antimicrobial resistance.
    Dubey KK; Indu ; Sharma M
    Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000168. PubMed ID: 32776618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing of Existing Statin Drugs for Treatment of Microbial Infections: How Much Promising?
    Rana R; Sharma R; Kumar A
    Infect Disord Drug Targets; 2019; 19(3):224-237. PubMed ID: 30081793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.
    Tarín-Pelló A; Suay-García B; Pérez-Gracia MT
    Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1095-1108. PubMed ID: 35576494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing old drugs to fight multidrug resistant cancers.
    Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
    Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug repurposing for the treatment of staphylococcal infections.
    Thangamani S; Mohammad H; Younis W; Seleem MN
    Curr Pharm Des; 2015; 21(16):2089-100. PubMed ID: 25760334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Beyond Antimicrobials: Non-traditional Approaches to Combating Multidrug-Resistant Bacteria.
    Kirienko NV; Rahme L; Cho YH
    Front Cell Infect Microbiol; 2019; 9():343. PubMed ID: 31681623
    [No Abstract]   [Full Text] [Related]  

  • 17. Repurposed drug candidates for antituberculosis therapy.
    An Q; Li C; Chen Y; Deng Y; Yang T; Luo Y
    Eur J Med Chem; 2020 Apr; 192():112175. PubMed ID: 32126450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections.
    Soo VW; Kwan BW; Quezada H; Castillo-Juárez I; Pérez-Eretza B; García-Contreras SJ; Martínez-Vázquez M; Wood TK; García-Contreras R
    Curr Top Med Chem; 2017; 17(10):1157-1176. PubMed ID: 27697046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections.
    Younis W; Thangamani S; Seleem MN
    Curr Pharm Des; 2015; 21(28):4106-11. PubMed ID: 25961308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing auranofin for the treatment of cutaneous staphylococcal infections.
    Thangamani S; Mohammad H; Abushahba MF; Sobreira TJ; Seleem MN
    Int J Antimicrob Agents; 2016 Mar; 47(3):195-201. PubMed ID: 26895605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.